• Home
  • NEW DAY MEDICINE
  • 10 (84) 2025
  • 8 -10 (84) 2025 - Ulugbekova G.J., Mamajonov Z.A., Mamatova I.Y. - TUMOR-ASSOCIATED MACROPHAGES (TAMS) AND THEIR BIOLOGICAL FUNCTIONS

8 -10 (84) 2025 - Ulugbekova G.J., Mamajonov Z.A., Mamatova I.Y. - TUMOR-ASSOCIATED MACROPHAGES (TAMS) AND THEIR BIOLOGICAL FUNCTIONS

TUMOR-ASSOCIATED MACROPHAGES (TAMS) AND THEIR BIOLOGICAL FUNCTIONS

Z.A. Akhadova - Andijan State Medical Institute

Resume

Tumor-associated macrophages (TAMs) are one of the most abundant immune cell populations in the tumor microenvironment (TME). By interacting with tumor and stromal cells, TAMs promote angiogenesis, suppress adaptive immunity, and facilitate metastasis. Most TAMs resemble the M2-like phenotype, secreting immunosuppressive and pro-tumorigenic factors such as IL-10, TGF-β, and VEGF. Their functional reprogramming has been recognized as a promising target in cancer immunotherapy.

Keywords: Tumor-associated macrophages (TAMs), M1/M2 polarization, angiogenesis, immunosuppression, metastasis, cancer therapy.

First page

50

Last page

52

For citation:Ulugbekova G.J., Mamajonov Z.A., Mamatova I.Y. - TUMOR-ASSOCIATED MACROPHAGES (TAMS) AND THEIR BIOLOGICAL FUNCTIONS//New Day in Medicine 10(84)2025 50-52 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

  1. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51.
  2. Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017 Jul;14(7):399–416.
  3. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011 Nov;11(11):723–37.
  4. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014 Jul; 41(1):49–61.
  5. Lin EY, Pollard JW. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 2007;67(11):5064–6.
  6. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010 Oct; 11(10):889–96.
  7. Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017 May; 545(7655):495–9.
  8. Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol. 2006;80(4):705–13.
  9. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006 Jan; 124(2):263–6.
  10. Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014 Oct; 513(7519):559–63.
  11. Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell. 2014;25(6):846–59.
  12. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science. 2011;331(6024):1612–6.
  13. DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019 Jun; 19(6):369–82.

    file

    download